You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-932-ESGO Stereotactic body radiotherapy boost as an alternative for locally advanced cervical cancer when brachytherapy is not available, a prospective monocentric phase II

Alerts

Article menu

Download PDFPDF

Cervical cancer
2022-RA-932-ESGO Stereotactic body radiotherapy boost as an alternative for locally advanced cervical cancer when brachytherapy is not available, a prospective monocentric phase II
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address